ArticleBMC pregnancy and childbirth2026
Impact of three-month tuberculosis preventive treatment (3HP) on IVF-ET outcomes in infertile women with tuberculosis infection: a retrospective before-after study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis retrospective before-after study aimed to evaluate whether tuberculosis preventive treatment (TPT) for tuberculosis infection (TBI, previously referred to as "latent TB infection" or LTBI) is associated with improved pregnancy outcomes in infertile women undergoing in vitro fertilization and embryo transfer (IVF-ET), and whether outcomes differ by the TPT duration and embryo origin.
methodsAll participants initiated the WHO-recommended 3HP regimen (once-weekly isoniazid plus rifapentine; 12 doses over 3 months) after active TB was excluded. In this retrospective real-world cohort, the total documented duration of combination therapy varied in the medical record (3-18 months). Using a within-patient design, we compared pregnancy outcomes between embryo transfer cycles conducted before and after TPT. Post-TPT cycles were further stratified by TPT duration (3 months, 6 months, 12 months, 18 months) and embryo origin (embryos were cryopreserved from a cycle prior to TPT or derived after TPT ) to compare pregnancy outcomes within each stratum.
resultsAfter TPT, biochemical pregnancy, clinical pregnancy, and live birth rates increased significantly, while early miscarriage rates decreased. Live birth rates did not differ significantly across the TPT duration subgroups (range: 32.69-39.29%). Among women with recurrent implantation failure, the live birth rate increased to 34.38% after TPT. Pregnancy outcomes did not differ by embryo origin.
conclusionsIn infertile women with TBI undergoing IVF-ET, initiation of TPT with the guideline-recommended 3-month 3HP regimen was associated with improved pregnancy outcomes. In exploratory analyses, longer documented durations beyond 3 months were not associated with higher live-birth rates, supporting consideration of the standard course while acknowledging residual confounding inherent to this retrospective design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.